MediWound (MDWD) Competitors

MediWound (NASDAQ:MDWD) and Avadel Pharmaceuticals (NASDAQ:AVDL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, valuation and community ranking.

Do analysts prefer MDWD or AVDL?

MediWound presently has a consensus target price of $31.33, suggesting a potential upside of 91.64%. Avadel Pharmaceuticals has a consensus target price of $19.88, suggesting a potential upside of 151.26%. Given Avadel Pharmaceuticals' higher possible upside, analysts clearly believe Avadel Pharmaceuticals is more favorable than MediWound.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Avadel Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger earnings & valuation, MDWD or AVDL?

MediWound has higher earnings, but lower revenue than Avadel Pharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than MediWound, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$20.22M	8.74	-$6.72M	-$3.07	-5.33
Avadel Pharmaceuticals	$169.12M	4.52	-$160.28M	-$0.52	-15.21

Is MDWD or AVDL more profitable?

Avadel Pharmaceuticals has a net margin of -52.53% compared to MediWound's net margin of -142.29%. MediWound's return on equity of -82.17% beat Avadel Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediWound	-142.29%	-82.17%	-33.67%
Avadel Pharmaceuticals	-52.53%	-93.34%	-44.77%

Which has more volatility and risk, MDWD or AVDL?

MediWound has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Avadel Pharmaceuticals has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500.

Does the MarketBeat Community prefer MDWD or AVDL?

MediWound received 47 more outperform votes than Avadel Pharmaceuticals when rated by MarketBeat users. However, 66.54% of users gave Avadel Pharmaceuticals an outperform vote while only 62.23% of users gave MediWound an outperform vote.

Company	Underperform	Outperform
MediWound	Outperform Votes 397 62.23%	Underperform Votes 241 37.77%
Avadel Pharmaceuticals	Outperform Votes 350 66.54%	Underperform Votes 176 33.46%

Do institutionals and insiders believe in MDWD or AVDL?

46.8% of MediWound shares are held by institutional investors. Comparatively, 69.2% of Avadel Pharmaceuticals shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 4.8% of Avadel Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media prefer MDWD or AVDL?

In the previous week, Avadel Pharmaceuticals had 9 more articles in the media than MediWound. MarketBeat recorded 12 mentions for Avadel Pharmaceuticals and 3 mentions for MediWound. MediWound's average media sentiment score of 0.87 beat Avadel Pharmaceuticals' score of 0.73 indicating that MediWound is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MediWound	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avadel Pharmaceuticals	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Avadel Pharmaceuticals beats MediWound on 9 of the 17 factors compared between the two stocks.